# Erytech Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/erytech-pharma

- Industry: Biotechnology
- Headquarters: Lyon, France
- Website: www.erytech.com
- Total disclosed funding: $46M
- Latest round: Series D (Apr 1, 2013)
- Investors on record: 5

## About

Erytech Pharma SA, based in Lyon, France, is engaged in the development of innovative therapies for severe medical conditions, focusing on advanced treatments for cancer and rare diseases.Founded in 2004 in Lyon, France, Erytech Pharma SA specializes in developing innovative treatments for cancer and rare diseases. The company has undergone strategic business shifts to enhance its focus on these therapeutic areas. It was founded by Yann Godfrin, who has a history of entrepreneurial ventures in the biopharmaceutical field. The company has raised EUR 125.000 mn through various funding rounds, with its latest funding round being a PIPE of EUR 25.400 mn. Erytech Pharma has completed a total of 12 deals in its operational history.Erytech Pharma SA specializes in developing innovative therapies aimed at treating cancer and rare diseases. The company focuses on creating targeted treatment solutions that address unmet medical needs in these critical areas, potentially incorporating cutting-edge biopharmaceutical technologies into their product pipeline.In the most recent fiscal year of 2023, Erytech Pharma SA reported a revenue of EUR 140027.2 and an EBITDA of EUR -25281557.1.Erytech Pharma plans to leverage its recent PIPE funding to expand its product pipeline and accelerate the development of new therapies targeting cancer and rare diseases. The company aims to explore new geographic markets in Europe and North America by the end of 2024, enhancing its reach and impact in the biopharmaceutical sector. With all VC investors having exited their stake, Erytech Pharma is positioned to focus on its core therapeutic developments and navigate future opportunities in the industry.

## Funding rounds

- Series D, Apr 1, 2013, $23M — Auriga Partners, Eurazeo
- Series A, Aug 12, 2010, $6.8M — Auriga Partners, Ardian, Eurazeo, Karista, Rhone-Alpes Creation
- Series A, Aug 28, 2009, $5.7M — Auriga Partners, Ardian, Eurazeo, Karista, Rhone-Alpes Creation
- Series A, Apr 26, 2007, $11M — Auriga Partners, Ardian, Eurazeo, Karista, Rhone-Alpes Creation

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series D
- Ardian (https://capitalatlas.ai/funds/ardian) — Series A
- Eurazeo (https://capitalatlas.ai/funds/eurazeo) — Series A, Series D
- Karista (https://capitalatlas.ai/funds/karista) — Series A
- Rhone-Alpes Creation (https://capitalatlas.ai/funds/rhone-alpes-creation) — Series A